Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
A new method screens large libraries of synthetic cyclic peptides to identify co...
Next-generation MS platforms are transforming drug discovery by revealing comple...
Macrocycles, de novo antibodies, and mRNA therapies are expanding the drug disco...
In this thought leader piece Laurence Arnold, PhD, head of R&D at Pelago Bioscie...
In a quest to provide more relevant translational data, traditional in vivo mode...
In this June issue Thought Leader article, David A. George of Scripps Laboratori...
Researchers utilize health data to inform medical breakthroughs, but patients ne...
Promega’s nonlytic, bioluminescent bioassay platform that distinguishes bystande...
In discovery and preclinical studies, endotoxins are silent disruptors of animal...
Throughput is no longer the bottleneck. Sensitivity is. A platform that captures...
Sponsored content brought to you by Historical data indicate that animal models ...
Inflammatory pathways involving microglia, astrocytes, and cytokine signaling ar...
As FDA support for NAMs accelerates, Corning is helping researchers standardize,...
In early discovery, researchers use high-throughput screening (HTS) to identify ...
Why maintaining translational continuity across preclinical research models can ...
This marks the first approved immunotherapy combination for this patient segment...
